Israeli Researchers Develop First mRNA Vaccine Against Antibiotic-Resistant Bacteria
Israeli researchers from Tel Aviv University have developed the world's first mRNA-based vaccine against Yersinia pestis, the bacterium causing bubonic plague, demonstrating 100% protection in animal models and highlighting its potential for preventing deadly bacterial infections and bioterrorism threats.